Virginia Borges, University of Colorado Cancer Center (IMAGE)

University of Colorado Anschutz

Virginia Borges, University of Colorado Cancer Center

Caption

Virginia Borges, M.D., M.M.Sc. and colleagues present phase 1b results showing promise of ONT-380 against HER2+ breast cancer, especially against brain metastases associated with disease.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.